Evidence map›Paper›PMID 27003591›Full record

ReviewHeart failure reviews2016

The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.

Phillip A Weeks, Adam Sieg, Jennifer Ann Gass, Indranee Rajapreyar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Phillip A WeeksDepartment of Pharmacy, Memorial Hermann - Texas Medical Center, 6411 Fannin Street, Houston, TX, 77030, USA. phillip.weeks@memorialhermann.org.
Adam SiegDepartment of Pharmacy, Memorial Hermann - Texas Medical Center, 6411 Fannin Street, Houston, TX, 77030, USA.
Jennifer Ann GassDepartment of Pharmacy, Memorial Hermann - Texas Medical Center, 6411 Fannin Street, Houston, TX, 77030, USA.
Indranee RajapreyarCenter for Advanced Heart Failure, University of Texas Health Science Center, 6400 Fannin Street, Suite 2300, Houston, TX, 77030, USA.
Memorial Hermann–Texas Medical Center · USThe University of Texas Health Science Center at Houston · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sudden cardiac death remains a significant threat to the survival of patients with heart failure. Long-term cardiac remodeling predisposes these patients to develop malignant ventricular arrhythmias. Permanent implantable and temporary external defibrillators remain a mainstay for the prevention of sudden cardiac death in this population. For decades, researchers have attempted to identify reliable drug therapies to avoid such arrhythmias; however, to date, success has been inconsistent. This review aims to explore the evidence defining the role of drug therapies for direct and indirect suppression of arrhythmias that may cause sudden cardiac death in patients with heart failure.

Indexed as

Anti-Arrhythmia AgentsDeath, Sudden, CardiacDefibrillators, ImplantableHeart FailureHumansRandomized Controlled Trials as TopicVentricular FibrillationAnti-Arrhythmia AgentsAntiarrhythmic drugsHeart failurePharmacotherapy preventionSudden cardiac deathVentricular arrhythmiaVentricular fibrillation

Identifiers

PMID27003591
OpenAlexW2302743301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.